Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction
NCT ID: NCT02925026
Last Updated: 2018-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
235 participants
INTERVENTIONAL
2016-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae
NCT05519254
The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 6-11 Months
NCT02472262
Randomized, Controlled Trial - Lactoferrin Prevention of Diarrhea in Children
NCT00560222
The Effect of Bovine Colostrum/ Egg Supplementation in Young Malawian Children
NCT03801317
The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 1-3 Year Olds
NCT02472301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactoferrin+Lysozyme
lactoferrin and lysozyme in rice flour
Lactoferrin
Lysozyme
Placebo
rice flour
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactoferrin
Lysozyme
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* youngest eligible child in each household
Exclusion Criteria
* severe chronic illness
* children unable to drink 20 mL of dual sugar solution
* children in need of acute medical treatment for illness or injury at time of enrollment
12 Months
35 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Malawi
OTHER
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark J Manary, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University in St. Louis; University of Malawi
Chrissie Thakwalakwa, PhD
Role: STUDY_DIRECTOR
Study Director
Indi Trehan, MD MPH DTM&H
Role: STUDY_DIRECTOR
Washington University in St. Louis; University of Malawi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Malawi
Blantyre, , Malawi
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cheng WD, Wold KJ, Benzoni NS, Thakwalakwa C, Maleta KM, Manary MJ, Trehan I. Lactoferrin and lysozyme to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for a randomized controlled trial. Trials. 2017 Nov 6;18(1):523. doi: 10.1186/s13063-017-2278-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Lactoferrin-Lysozyme
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.